Effectiveness and safety of liraglutide in managing inadequate weight loss and weight regain after primary and revisional bariatric surgery: anthropometric and cardiometabolic outcomes
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis MARKET DYNAMICS Stringent cost and payer controls OPPORTUNITIES Impact Level Increasing studies on oral GLP-1 Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis Rapid expansion of manufacturing capacity is driving growth across the pharmaceutical market, especially for high-demand drugs like GLP-1 analogs
What states is NiceRx available
These state health programs (called DSHPs) do not otherwise qualify for federal funding, must have existed prior to 1115 waiver implementation, and often provide safety-net health care services for low-income or uninsured individuals (such as addiction recovery treatment or support for individuals with intellectual and developmental disabilities)
Mash Treatment Support Metabolic Dysfunction-Associated Steatohepatitis (MASH), formerly known as NASH, is a growing global health concern